Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19239166 | 0.96 | GPR3 (0.37) | KDM4EMAOAMAOBALDH1A1CYP1A2 | |
| SCHEMBL22925206 | 0.91 | MEN1 (0.34) | KDM4EMAOAMAOBALDH1A1MAPT | |
| SCHEMBL19239134 | 0.89 | AHR (0.40) | KDM4EALDH1A1MAPT | |
| SCHEMBL21398782 | 0.84 | MCL1 (0.38) | KDM4EMAOAMAOBALDH1A1CYP1A2 | |
| SCHEMBL24000244 | 0.84 | MAPT (0.42) | KDM4EMAOAMAOBALDH1A1CYP1A2 | |
| SCHEMBL15852566 | 0.84 | KDM4E (0.33) | KDM4EMAOAMAOBALDH1A1CYP1A2 | |
| SCHEMBL21398641 | 0.83 | GPR3 (0.38) | KDM4EMAOAMAOBALDH1A1CYP1A2 | |
| SCHEMBL21398613 | 0.82 | KDM4E (0.32) | KDM4EMAOAMAOB | |
| SCHEMBL21936415 | 0.82 | KDM4E (0.32) | KDM4EMAOAMAOB | |
| SCHEMBL15852623 | 0.82 | NQO2 (0.36) | KDM4EMAOAMAOBALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210028370-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2021-01-28 | — | — | US | disclosed |
| US-10651391-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20190245148-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2019-08-08 | — | — | US | disclosed |
| US-10319915-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2019-06-11 | — | — | US | disclosed |
| US-20180151806-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-31 | — | — | US | disclosed |
| US-20180151806-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10319915-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | EML4, EBPL, NFE2L2 | KDM4E 902/4885MAOA 1163/4885MAOB 1996/4885 |
| US-20210028370-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR | OR51E2, WEE1, SLC39A11 | KDM4E 1966/4885MAOA 2243/4885MAOB 3275/4885 |
| US-20190245148-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EML4, EBPL, NFE2L2 | KDM4E 902/4885MAOA 1163/4885MAOB 1996/4885 |
| US-20180151806-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EBPL, EML4, NFE2L2 | KDM4E 853/4885MAOA 1491/4885MAOB 2390/4885 |
| US-10651391-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | EML4, EBPL, NFE2L2 | KDM4E 902/4885MAOA 1163/4885MAOB 1996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.